Role of a Novel Corepressor in Nuclear Receptor Action
Role of a Novel Corepressor in Nuclear Receptor Action
批准号:
7217882
负责人:
NICHOLAS R MARSH-ARMSTRONG
金额:
$28.73万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-05 至 2011-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long term goal of this work is to understand how gene regulatory networks controlled by hormones regulate developmental and physiological processes. Nuclear receptors mediate the actions of a variety of hormones by activating the expression of specific genes. Some nuclear receptors can also repress transcription by association with corepressors, but less is known about the mechanisms and significance of repression. This study focuses on a novel nuclear receptor corepressor, the protein encoded by the mammalian Hairless (Hr) gene. This laboratory has demonstrated that the Hairless (HR) protein influences the function of multiple nuclear receptors, including thyroid hormone receptors, vitamin D receptor, and an orphan receptor, ROR. HR functions in many tissues, most prominently in skin as mutations in the Hr gene cause (alopecia) hair loss in humans and mice. Our central hypothesis is that HR influences the expression of downstream hormone-responsive genes in vivo, and that the Hr mutant phenotype arises from specific changes in gene expression. One goal of the proposed research is to determine the molecular mechanisms by which HR acts as a transcriptional represser, and will include the identification of specific proteins, including other nuclear receptors, that interact with HR. Defining the signaling pathways influenced by HR will include the identification of specific target genes that are regulated by HR; based on our recent data, candidate target genes include specific inhibitors of Wnt signaling. The Wnt signaling pathway plays an essential role in tissue development and homeostasis, and disruptions in Wnt signaling are associated with cancer. A second goal is to test HR function in vivo using genetically engineered mice. Recent analysis of mice lacking HR expression has revealed a potential role in regulating stem cell differentiation, a model that will be tested using transgenic mice. Defining the role of HR using skin as a model system will provide insight into diverse biological processes, as HR also influences the activity of receptors that mediate brain development, bone formation and mineral metabolism. Nuclear receptors are already successful therapeutic targets for the treatment of diseases such as diabetes. Understanding the molecular pathway of HR corepressor action will help define a specific mechanism of regulating nuclear receptor function, which in turn may reveal potential sites of intervention to treat developmental and physiologic disorders. Hormones regulate biological processes such as growth and development via nuclear receptors. This work will allow us to understand a specific way of regulating nuclear receptor function, which should be useful for designing therapeutic agents for treating developmental and physiologic disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optic nerve head glymphatics and debris clearance in glaucoma
-
批准号:10200062
-
项目类别:
-
资助金额:$52.86万
-
财政年份:2018
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Optic nerve head glymphatics and debris clearance in glaucoma
-
批准号:10455455
-
项目类别:
-
资助金额:$49.7万
-
财政年份:2018
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Axonal mitochondria degradation as the Achilles heel of retinal ganglion cells
-
批准号:9899992
-
项目类别:
-
资助金额:$44.36万
-
财政年份:2016
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Axonal mitochondria degradation as the Achilles heel of retinal ganglion cells
-
批准号:9198767
-
项目类别:
-
资助金额:$44.36万
-
财政年份:2016
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Optic nerve head synucleinopathy in glaucoma and the function of gamma-synuclein
-
批准号:8500298
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2011
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Optic nerve head synucleinopathy in glaucoma and the function of gamma-synuclein
-
批准号:8042280
-
项目类别:
-
资助金额:$40.4万
-
财政年份:2011
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Optic nerve head synucleinopathy in glaucoma and the function of gamma-synuclein
-
批准号:8298971
-
项目类别:
-
资助金额:$40.4万
-
财政年份:2011
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
GAMMA SYNUCLEIN AGGREGATES AND GLAUCOMA
-
批准号:8361930
-
项目类别:
-
资助金额:$2.47万
-
财政年份:2011
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
GAMMA SYNUCLEIN AGGREGATES AND GLAUCOMA
-
批准号:8169646
-
项目类别:
-
资助金额:$2.39万
-
财政年份:2010
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Role of a Novel Corepressor in Nuclear Receptor Action
-
批准号:7369766
-
项目类别:
-
资助金额:$28.24万
-
财政年份:2006
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Role of a Novel Corepressor in Nuclear Receptor Action
-
批准号:7597079
-
项目类别:
-
资助金额:$28.27万
-
财政年份:2006
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Photoreceptor Degeneration Assay-Transgenic Xenopus(RMI)
-
批准号:7021338
-
项目类别:
-
资助金额:$18.3万
-
财政年份:2005
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Thyroid hormone & metamorphic ipsilateral projection
-
批准号:7172223
-
项目类别:
-
资助金额:$39.08万
-
财政年份:2004
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Thyroid hormone & metamorphic ipsilateral projection
-
批准号:7341601
-
项目类别:
-
资助金额:$38.3万
-
财政年份:2004
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Thyroid hormone & metamorphic ipsilateral projection
-
批准号:6983394
-
项目类别:
-
资助金额:$39.3万
-
财政年份:2004
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Thyroid hormone & metamorphic ipsilateral projection
-
批准号:6852954
-
项目类别:
-
资助金额:$36.23万
-
财政年份:2004
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Novel-miR-1134调控LHCGR的表达介导拟
穴青蟹卵巢发育的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:崔文晓
-
依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
-
批准号:82304677
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:边兴博
-
依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
-
批准号:82304658
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘亚
-
依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
-
批准号:32102747
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李婉雁
-
依托单位:
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:唐晓冰
-
依托单位:
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:张瑜
-
依托单位:
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
-
批准号:82070530
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:白玉作
-
依托单位:
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
-
批准号:32002421
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:修云吉
-
依托单位:
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
-
批准号:82072775
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:薛皓
-
依托单位:
miRNA/novel_167靶向抑制Dmrt1的表达在红鳍东方鲀性别分化过程中的功能研究
-
批准号:31902347
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2019
-
负责人:闫红伟
-
依托单位: